Literature DB >> 22535573

Increasing incidence of pediatric inflammatory bowel disease in Spain (1996-2009): the SPIRIT Registry.

Javier Martín-de-Carpi1, Alejandro Rodríguez, Esther Ramos, Santiago Jiménez, María José Martínez-Gómez, Enrique Medina.   

Abstract

BACKGROUND: Although pediatric inflammatory bowel disease (IBD) diagnosis has increased in the last decades in Spain, there are no consistent epidemiologic data. Our aim was to describe the changing pattern of pediatric IBD incidence in Spain in the last 14 years.
METHODS: A retrospective survey of patients diagnosed below 18 years of age in the period 1996-2009 was performed. Patients' data were obtained from the hospitals' databases. To avoid reduced accrual of cases diagnosed by adult physicians, adult IBD units in referral centers were invited to participate. Seventy-eight centers participated in our survey. Rates of incidence were calculated using age-stratified population-based epidemiologic data. Incidence rates were compared for the last 14 years (1996-2009).
RESULTS: In total, data from 2107 patients were obtained: 1,165 Crohn's disease (CD, 55.3%), 788 ulcerative colitis (UC, 37.4%), and 154 IBD unclassified. The sex distribution was 56.4% male, with higher predominance for CD (59.3%) as compared to UC (52.8%) and IBD unclassified (53.2%) (P = 0.012). The median age at diagnosis was 12.3 years (p25-75 9.7-14.6) with significant differences between diseases. IBD incidence increased from 0.97 to 2.8/100,000 inhabitants <18 years/year in the study period. Although this increase is more evident for CD (from 0.53 to 1.7), UC has also risen considerably (0.39 to 0.88).
CONCLUSIONS: This is the first attempt to calculate the current incidence of pediatric IBD in Spain. A significant increase of incidence rates in the study period was observed. In the last 14 years pediatric IBD incidence has almost tripled, with a more important CD increase.

Entities:  

Mesh:

Year:  2013        PMID: 22535573     DOI: 10.1002/ibd.22980

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  30 in total

Review 1.  The microbiome in inflammatory bowel disease: current status and the future ahead.

Authors:  Aleksandar D Kostic; Ramnik J Xavier; Dirk Gevers
Journal:  Gastroenterology       Date:  2014-02-19       Impact factor: 22.682

Review 2.  Associations between single-nucleotide polymorphisms and inflammatory bowel disease-associated colorectal cancers in inflammatory bowel disease patients: a meta-analysis.

Authors:  H Li; Z Jin; X Li; L Wu; J Jin
Journal:  Clin Transl Oncol       Date:  2017-02-27       Impact factor: 3.405

Review 3.  Optimization of Inflammatory Bowel Disease Cohort Studies in Asia.

Authors:  Wai K Leung
Journal:  Intest Res       Date:  2015-06-09

4.  Enteroclysis: Current clinical value.

Authors:  Adel Maataoui; Thomas J Vogl; Volkmar Jacobi; M Fawad Khan
Journal:  World J Radiol       Date:  2013-07-28

Review 5.  Quality improvement in pediatric inflammatory bowel disease: moving forward to improve outcomes.

Authors:  Pauline Quach; Geoffrey C Nguyen; Eric I Benchimol
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

6.  Expression of CD200R1 and its Ligand CD200 on T-helper Lymphocytes of Pediatric Patients with Ulcerative Colitis and Crohn's Disease.

Authors:  Mohamed F Elshal; Alia M Aldahlawi; Omar I Saadah; J Philip Mccoy
Journal:  Clin Lab       Date:  2016-08-01       Impact factor: 1.138

7.  Pediatric Inflammatory Bowel Disease: A Multicenter Study of Changing Trends in Argentina Over the Past 30 Years.

Authors:  Maria Soledad Arcucci; Monica Beatriz Contreras; Julieta Gallo; Mariela Andrea Antoniska; Veronica Busoni; Cecilia Tennina; Daniel D'Agostino; Maria Hisae Kakisu; Christian Weyersberg; Marina Orsi
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2022-05-09

8.  A Saudi Gastroenterology association position statement on the use of tumor necrosis factor-alfa antagonists for the treatment of inflammatory bowel disease.

Authors:  Mahmoud H Mosli; Othman Al-Harbi; Brian G Feagan; Majid A Almadi
Journal:  Saudi J Gastroenterol       Date:  2015 Jul-Aug       Impact factor: 2.485

Review 9.  Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel disease.

Authors:  Parambir S Dulai; Corey A Siegel; Marla C Dubinsky
Journal:  Inflamm Bowel Dis       Date:  2013-12       Impact factor: 5.325

10.  The microaerophilic microbiota of de-novo paediatric inflammatory bowel disease: the BISCUIT study.

Authors:  Richard Hansen; Susan H Berry; Indrani Mukhopadhya; John M Thomson; Karin A Saunders; Charlotte E Nicholl; W Michael Bisset; Sabarinathan Loganathan; Gamal Mahdi; Dagmar Kastner-Cole; Andy R Barclay; Jon Bishop; Diana M Flynn; Paraic McGrogan; Richard K Russell; Emad M El-Omar; Georgina L Hold
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.